Korea Investment Corp’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-17,934
Closed -$2.26M 743
2024
Q2
$2.26M Buy
17,934
+3,409
+23% +$534K 0.01% 674
2024
Q1
$2.67M Sell
14,525
-931
-6% -$177K 0.01% 676
2023
Q4
$2.78M Buy
15,456
+1,571
+11% +$245K 0.01% 662
2023
Q3
$2.21M Sell
13,885
-648
-4% -$106K 0.01% 651
2023
Q2
$2.06M Sell
14,533
-2,179
-13% -$349K 0.01% 658
2023
Q1
$2.81M Sell
16,712
-310
-2% -$55.3K 0.01% 627
2022
Q4
$2.88M Buy
+17,022
New +$3.09M 0.01% 641

Other funds holding RGEN

Korea Investment Corp's RGEN Position: Q3 2024 in Review

Korea Investment Corp sold out of Repligen (RGEN) in Q3 2024, closing a stake of 17,934 shares — an estimated $2.26M sold.

Korea Investment Corp first reported a position in RGEN in Q4 2022 and held it in 7 quarters. The position peaked at $2.88M in Q4 2022. 444 funds tracked by Wall St. Rank hold RGEN as of Q3 2024.

  • Korea Investment Corp reported no remaining Repligen position as of Q3 2024 after selling out during the quarter.
  • Korea Investment Corp sold 17,934 Repligen shares in Q3 2024, an estimated $2.26M.
  • Korea Investment Corp first reported a position in Repligen in Q4 2022 and held it in 7 quarters.
  • Korea Investment Corp's Repligen position peaked at $2.88M in Q4 2022.
  • 444 funds tracked by Wall St. Rank held Repligen as of Q3 2024.

Based on Korea Investment Corp's 13F filing for Q3 2024, filed 13 Nov 2024.